Refractive outcome of premature infants with or without retinopathy of prematurity at 2 years of age: a prospective controlled cohort study
- PMID: 22453068
- PMCID: PMC11916860
- DOI: 10.1016/j.kjms.2011.10.010
Refractive outcome of premature infants with or without retinopathy of prematurity at 2 years of age: a prospective controlled cohort study
Abstract
This study evaluated the extent to which refractive morbidity is correlated to preterm birth or retinopathy of prematurity (ROP) itself, or both, and examined the risk factors associated with refractive errors in a cohort of preterm infants with and without ROP compared with full-term infants. This longitudinal, prospective, controlled cohort study enrolled 109 infants, including 74 preterm and 35 full-term infants. Infants were divided into the following groups: no ROP, regressed ROP, laser-treated threshold ROP, and full-term. Cycloplegic refraction was determined at 6 and 24 months' corrected age. Multiple regression models, analysis of variance (ANOVA) with post hoc comparisons, paired t test, and the χ(2) test were used for data analysis. ROP status was highly predictive of significant refractive errors in preterm infants. Eyes with laser-treated threshold ROP had significant myopia at both ages (mean spherical equivalent [MSE] in right eye at both refractions -0.72, -1.21 diopters [D]), astigmatism (MSE -1.62, -1.80 D), and anisometropia (MSE 0.82, 1.02 D; ANOVA p < 0.05), and increased refractive errors across ages (paired t test p < 0.05). Eyes with regressed ROP (MSE + 0.35 D) and eyes without ROP (MSE + 0.78 D) were less hyperopic than the controls (MSE + 1.60 D) before 1 year (post hoc comparisons p < 0.05). After 1 year, however, hyperopic status, astigmatism, and anisometropia were similar to eyes with regressed ROP (MSE + 0.38 D, astigmatism -0.94 D, anisometropia 0.32 D), eyes without ROP (MSE + 0.35 D, astigmatism -0.51 D, anisometropia 0.31 D) and the controls (MSE + 0.72 D, astigmatism -0.59 D, anisometropia 0.50 D) by post hoc comparisons (p > 0.05). Thus, the persistent hyperopic status across ages in patients with regressed ROP and in patients without ROP differed significantly (paired t test p > 0.05) from that in the full-term infants, with a reduction in hypermetropia noted for the first 2 years of life (paired t test p < 0.05). The incidence and magnitude of significant refractive errors increased with severe ROP and with age. Although the emmetropization process of preterm birth, including regressed ROP and no ROP, differed from full-term birth in early infancy, we found no differences in the refractive status after 1 year in patients with regressed ROP and in patients without ROP, who were at risk of developing ametropia similar to that of full-term patients. Therefore, apart from laser-treated ROP, children with regressed ROP and without ROP can likely be observed with a verbal vision screening at 3-4 years of age.
Copyright © 2012. Published by Elsevier B.V.
Similar articles
-
Development of refractive error in individual children with regressed retinopathy of prematurity.Invest Ophthalmol Vis Sci. 2013 Sep 5;54(9):6018-24. doi: 10.1167/iovs.13-11765. Invest Ophthalmol Vis Sci. 2013. PMID: 23920368 Free PMC article.
-
Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.Ophthalmology. 1998 Jul;105(7):1292-300. doi: 10.1016/s0161-6420(98)97036-1. Ophthalmology. 1998. PMID: 9663236
-
Treated threshold stage 3 versus spontaneously regressed subthreshold stage 3 retinopathy of prematurity: a study of motility, refractive, and anatomical outcomes at 6 months and 36 months.Br J Ophthalmol. 2005 Feb;89(2):154-9. doi: 10.1136/bjo.2004.045815. Br J Ophthalmol. 2005. PMID: 15665344 Free PMC article.
-
Refractive status, biometric components, and functional outcomes of patients with threshold retinopathy of prematurity: systemic review and a 17-year longitudinal study.Graefes Arch Clin Exp Ophthalmol. 2022 Dec;260(12):3809-3816. doi: 10.1007/s00417-022-05730-6. Epub 2022 Jun 22. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35729410
-
Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review.PLoS One. 2019 Dec 2;14(12):e0225643. doi: 10.1371/journal.pone.0225643. eCollection 2019. PLoS One. 2019. PMID: 31790445 Free PMC article.
Cited by
-
The evolution of refractive status in Chinese infants during the first year of life and its affected factors.Int J Ophthalmol. 2017 Aug 18;10(8):1290-1294. doi: 10.18240/ijo.2017.08.17. eCollection 2017. Int J Ophthalmol. 2017. PMID: 28861357 Free PMC article.
-
Strabismus in Retinopathy of Prematurity: Risk Factors and the Effect of Macular Ectopia.Turk J Ophthalmol. 2023 Aug 19;53(4):241-246. doi: 10.4274/tjo.galenos.2023.48310. Turk J Ophthalmol. 2023. PMID: 37602650 Free PMC article.
-
Refractive status and optical components in premature infants with and without retinopathy of prematurity: A 4- to 5-year cohort study.Front Pediatr. 2022 Nov 17;10:922303. doi: 10.3389/fped.2022.922303. eCollection 2022. Front Pediatr. 2022. PMID: 36467469 Free PMC article.
-
Ocular outcomes and comorbidities in preterm infants enrolled for retinopathy of prematurity screening: A cohort study from western India.Oman J Ophthalmol. 2019 Jan-Apr;12(1):10-14. doi: 10.4103/ojo.OJO_221_2017. Oman J Ophthalmol. 2019. PMID: 30787528 Free PMC article.
-
Age-Related Effects on the Spectrum of Cerebral Visual Impairment in Children With Cerebral Palsy.Front Hum Neurosci. 2022 Mar 2;16:750464. doi: 10.3389/fnhum.2022.750464. eCollection 2022. Front Hum Neurosci. 2022. PMID: 35308614 Free PMC article.
References
-
- Quinn G.E., Dobson V., Kivlin J., Kaufman L.M., Repka M.X., Reynolds J.D., et al. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for retinopathy of prematurity cooperative group. Ophthalmology. 1998; 105: 1292–1300. - PubMed
-
- Quinn G.E., Dobson V., Davitt B.V., Hardy R.J., Tung B., Pedroza C., et al. Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age. Ophthalmology. 2008; 115: 1058–1064, e1051. - PubMed
-
- Davitt B.V., Dobson V., Good W.V., Hardy R.J., Quinn G.E., Siatkowski R.M., et al. Prevalence of myopia at 9 months in infants with high‐risk prethreshold retinopathy of prematurity. Ophthalmology. 2005; 112: 1564–1568. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources